Re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4
Eur Urol. 2019 Nov;76(5):e135-e136.
doi: 10.1016/j.eururo.2019.07.044.
Epub 2019 Aug 14.
1 Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
2 Euler Technology, Beijing, China; Center of Life Sciences, Peking University, Beijing, China.
3 Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China; Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: yu.xiao@whu.edu.cn.